Cell lines have been gaining increased attention for vaccine production, antibody production, and synthesis of biological compounds, among other applications during the ongoing COVID-19 pandemic. Such trends have been translating into revenue opportunities for companies in the cell line authentication and characterization tests market. This is evident since India completed administering one billion vaccine doses, and the region’s coronavirus cases have dropped significantly as compared to Russia and the U.K. where fresh infection cases are being registered.
Applied Biological Materials Inc. (abm) - a Canadian company that is constantly on the lookout for the latest innovations in life sciences research, is offering a unique collection of stable cell lines related to the coronavirus basic biology.
This is expected to drive the cell line authentication and characterization tests market during the forecast period.
The field of vision research is not exempt from the woes of misidentified cell lines. The human eye is a complex organ structure where specialized niches of cells reside. The choriocapillaris endothelium and retinal pigment epithelium are two examples of cell types that are frequently isolated for the study of blind eye diseases of the posterior pole of the eye, such as diabetic retinopathy, age-related macular degeneration, proliferative vitreoretinopathy, and the likes. The challenge of culturing these specialized cell types can be exacerbated by cell heterogeneity.
In order to ensure culture purity, laboratories are expected to consider implementing additional isolation methods such as magnetic-activated cell sorting (MACS) or fluorescence-activated cell sorting (FACS).
The cell line authentication and characterization tests market is projected to surpass US$ 753 Mn by 2031. Cell lines are fundamental research tools that serve as models for complex biological systems, especially those of human tissue. Thus, to enable meaningful tissue-specific conclusions in cell-based experiments and ensure reproducibility, it is imperative that cell lines accurately represent the cellular identities of its original source or donor.
Stakeholders in the cell line authentication and characterization tests market are unlocking revenue opportunities with a widely used method for cell line authentication, which involves STR (Short Tandem Repeat) profiling.
The cell line authentication and characterization tests market is expected to expand at a CAGR of 8.4% from 2021 to 2031. Custom cell authentication services are growing prominent in the cell line authentication and characterization tests market. ATCC or the American Type Culture Collection - a nonprofit organization which collects, stores, and distributes standard reference microorganisms, cell lines, and other materials for research & development, is gaining recognition for its custom cell authentication services.
The cell line authentication and characterization tests market is undergoing a significant change with standardized techniques for authentication that ensure valid and reproducible results. A range of services to authenticate and characterize the cells includes viability, sterility, and mycoplasma, among others.
Verifying the identity and purity of human cell lines is essential to the integrity of research activities. Companies in the cell line authentication and characterization tests market are increasing R&D in human cell authentication assays that identify short term repeat (STR) markers. Stakeholders in the cell line authentication and characterization tests market are making use of multiplex polymerase chain reaction (PCR) to simultaneously amplify the amelogenin gene and some of the most informative polymorphic markers in the human genome.
Companies in the cell line authentication and characterization tests market are adhering to ISO (International Organization of Standardization) standards to boost their credibility credentials. Routine testing of cell cultures is being carried out to prevent misidentification, cross contamination, and genetic drift. Cell authentication is also now required by the National Institutes of Health for grant funding and by a number of scientific journals.
Analysts’ Viewpoint
Cell lines for vaccine development and immortalized lung cell lines are being offered for research studies being conducted during the ongoing COVID-19 pandemic. Stakeholders are complying with cell authentication guidelines to boost credibility. Companies are increasing efforts to simplify human cell STR profiling. Expert analysis and easy-to-understand STR allele table is being preferred by researchers & scientists.
Due to the problem of cell line misidentification, companies in the cell line authentication and characterization tests market should offer standardized methods to ensure cell line identity and quality. Companies should increase efforts to provide authentication testing services designed to ensure consistency and reliability of research data.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 308 Mn |
|
Market Forecast Value in 2031 |
US$ 753 Mn |
|
Growth Rate (CAGR) |
8.4% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key industry events, etc. |
|
Competition Landscape |
Market share analysis by company (2020) |
|
Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc. |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Regions Covered |
North America |
|
Europe |
|
|
Asia Pacific |
|
|
Middle East & Africa |
|
|
South America |
|
|
Countries Covered |
U.S. |
|
Canada |
|
|
Germany |
|
|
U.K. |
|
|
France |
|
|
Italy |
|
|
Russia |
|
|
Japan |
|
|
China |
|
|
India |
|
|
South Korea |
|
|
ASEAN |
|
|
Brazil |
|
|
Mexico |
|
|
GCC Countries |
|
|
South Africa |
|
|
Companies Profiled |
Bio-Synthesis, Inc. |
|
Cell Line Genetics, Inc. |
|
|
Charles River Laboratories |
|
|
DNA Forensics Lab India |
|
|
Eurofins Genomics (Eurofins Scientific) |
|
|
GenomeScan |
|
|
IDEXX Laboratories, Inc. |
|
|
Laboratory Corporation of America Holdings |
|
|
Microsynth AG |
|
|
NorthGene Limited (Biofortuna Limited) |
|
|
Perfectus Biomed Limited |
|
|
Promega Corporation |
|
|
SGS SA |
|
|
Sigma-Aldrich Co. LLC. (Merck KGaA) |
|
|
Thermo Fisher Scientific, Inc. |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Cell Line Authentication and Characterization Tests Market – Segmentation
| Test Type |
|
| Application |
|
| End-user |
|
| Region |
|
Cell line authentication and characterization tests market is projected to surpass US$ 753 Mn by 2031
Cell line authentication and characterization tests market is expected to expand at a CAGR of 8.4% from 2021 to 2031
Cell line authentication and characterization tests market is driven by increase in geriatric population and surge in incidence of chronic diseases.
The short tandem repeat (STR) analysis segment dominated the global cell line authentication and characterization tests market and the trend is projected to continue during the forecast period.
Key players operating in the global cell line authentication and characterization tests market are Bio-Synthesis, Inc., Cell Line Genetics, Inc., Charles River Laboratories, DNA Forensics Lab India
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cell Line Authentication and Characterization Tests Market
4. Market Overview
4.1. Introduction
4.1.1. Test Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Standards for Cell Authentication and Characteristics
5.2. List of Cell Line Providers
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. Key Product/Brand Analysis
5.5. COVID-19 Pandemics Impact on Industry (value chain and short / mid /long term impact)
6. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Test Type, 2017–2031
6.3.1. Karyotype
6.3.2. Short Tandem Repeat (STR) Analysis
6.3.3. Single Nucleotide Polymorphism (SNP) Analysis
6.3.4. Others
6.4. Market Attractiveness Analysis, by Test Type
7. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Microbial Contamination
7.3.2. Cell Line Identity
7.3.3. Genetic Stability
7.3.4. Virus Testing
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Pharmaceutical & Biotechnology Companies
8.3.2. Academic & Research Institutes
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Sub-region/Region
10. North America Cell Line Authentication and Characterization Tests Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Test Type, 2017–2031
10.2.1. Karyotype
10.2.2. Short Tandem Repeat (STR) Analysis
10.2.3. Single Nucleotide Polymorphism (SNP) Analysis
10.2.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Microbial Contamination
10.3.2. Cell Line Identity
10.3.3. Genetic Stability
10.3.4. Virus Testing
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Pharmaceutical & Biotechnology Companies
10.4.2. Academic & Research Institutes
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Test Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Cell Line Authentication and Characterization Tests Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017–2031
11.2.1. Karyotype
11.2.2. Short Tandem Repeat (STR) Analysis
11.2.3. Single Nucleotide Polymorphism (SNP) Analysis
11.2.4. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Microbial Contamination
11.3.2. Cell Line Identity
11.3.3. Genetic Stability
11.3.4. Virus Testing
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Pharmaceutical & Biotechnology Companies
11.4.2. Academic & Research Institutes
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Test Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Cell Line Authentication and Characterization Tests Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017–2031
12.2.1. Karyotype
12.2.2. Short Tandem Repeat (STR) Analysis
12.2.3. Single Nucleotide Polymorphism (SNP) Analysis
12.2.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Microbial Contamination
12.3.2. Cell Line Identity
12.3.3. Genetic Stability
12.3.4. Virus Testing
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Pharmaceutical & Biotechnology Companies
12.4.2. Academic & Research Institutes
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia
12.6. Market Attractiveness Analysis
12.6.1. By Test Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Cell Line Authentication and Characterization Tests Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017–2031
13.2.1. Karyotype
13.2.2. Short Tandem Repeat (STR) Analysis
13.2.3. Single Nucleotide Polymorphism (SNP) Analysis
13.2.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Microbial Contamination
13.3.2. Cell Line Identity
13.3.3. Genetic Stability
13.3.4. Virus Testing
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Pharmaceutical & Biotechnology Companies
13.4.2. Academic & Research Institutes
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Test Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Cell Line Authentication and Characterization Tests Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Test Type, 2017–2031
14.2.1. Karyotype
14.2.2. Short Tandem Repeat (STR) Analysis
14.2.3. Single Nucleotide Polymorphism (SNP) Analysis
14.2.4. Others
14.3. Market Value Forecast By Application, 2017–2031
14.3.1. Microbial Contamination
14.3.2. Cell Line Identity
14.3.3. Genetic Stability
14.3.4. Virus Testing
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Pharmaceutical & Biotechnology Companies
14.4.2. Academic & Research Institutes
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Test Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis By Company (2020)
15.3. Company Profiles
15.3.1. Bio-Synthesis, Inc.
15.3.1.1. Company Description
15.3.1.2. Business Overview
15.3.1.3. SWOT Analysis
15.3.2. Cell Line Genetics, Inc.
15.3.2.1. Company Description
15.3.2.2. Business Overview
15.3.2.3. SWOT Analysis
15.3.3. Charles River Laboratories
15.3.3.1. Company Description
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.4. DNA Forensics Lab India
15.3.4.1. Company Description
15.3.4.2. Business Overview
15.3.4.3. SWOT Analysis
15.3.5. Eurofins Genomics (Eurofins Scientific)
15.3.5.1. Company Description
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.6. GenomeScan
15.3.6.1. Company Description
15.3.6.2. Business Overview
15.3.6.3. SWOT Analysis
15.3.7. IDEXX Laboratories, Inc.
15.3.7.1. Company Description
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.8. Laboratory Corporation of America Holdings
15.3.8.1. Company Description
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. Microsynth AG
15.3.9.1. Company Description
15.3.9.2. Business Overview
15.3.9.3. SWOT Analysis
15.3.10. NorthGene Limited (Biofortuna Limited)
15.3.10.1. Company Description
15.3.10.2. Business Overview
15.3.10.3. SWOT Analysis
15.3.11. Perfectus Biomed Limited
15.3.11.1. Company Description
15.3.11.2. Business Overview
15.3.11.3. SWOT Analysis
15.3.12. Promega Corporation
15.3.12.1. Company Description
15.3.12.2. Business Overview
15.3.12.3. Financial Overview
15.3.12.4. Strategic Overview
15.3.12.5. SWOT Analysis
15.3.13. SGS SA
15.3.13.1. Company Description
15.3.13.2. Business Overview
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.14. Sigma-Aldrich Co. LLC. (Merck KGaA)
15.3.14.1. Company Description
15.3.14.2. Business Overview
15.3.14.3. Financial Overview
15.3.14.4. Strategic Overview
15.3.14.5. SWOT Analysis
15.3.15. Thermo Fisher Scientific, Inc.
15.3.15.1. Company Description
15.3.15.2. Business Overview
15.3.15.3. Financial Overview
15.3.15.4. Strategic Overview
15.3.15.5. SWOT Analysis
List of Tables
Table 01: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 02: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 07: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 08: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 11: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 12: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 15: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 16: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 19: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 23: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 02: Global Cell Line Authentication and Characterization Tests Market Value Share (%), by Region, 2020
Figure 03: Global Cell Line Authentication and Characterization Tests Market Value Share (%), by Test Type, 2020
Figure 04: Global Cell Line Authentication and Characterization Tests Market Value Share (%), by Application, 2020
Figure 05: Global Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 06: Global Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Test Type, 2021–2031
Figure 07: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn), Karyotype, 2017–2031
Figure 08: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn), Short Tandem Repeat (STR) Analysis, 2017–2031
Figure 09: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn), Single Nucleotide Polymorphism (SNP) Analysis, 2017–2031
Figure 10: Global Cell Line Authentication and Characterization Tests Market Value (US$ Mn), Others, 2017–2031
Figure 11: Global Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2021 and 2031
Figure 12: Global Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031
Figure 13: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Microbial Contamination, 2017–2031
Figure 14: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Cell Line Identity, 2017–2031
Figure 15: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Genetic Stability, 2017–2031
Figure 16: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Virus Testing, 2017–2031
Figure 17: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Others, 2017–2031
Figure 18: Global Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031
Figure 19: Global Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031
Figure 20: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031
Figure 21: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Academic & Research Institutes, 2017–2031
Figure 22: Global Cell Line Authentication and Characterization Tests Market Revenue (US$ Mn), by Others, 2017–2031
Figure 23: Global Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Region, 2021 and 2031
Figure 24: Global Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Region, 2021–2031
Figure 25: North America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 26: North America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country, 2020 and 2031
Figure 27: North America Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country, 2021–2031
Figure 28: North America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 29: North America Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031
Figure 30: North America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031
Figure 31: North America Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031
Figure 32: North America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031
Figure 33: North America Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031
Figure 34: Europe Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 35: Europe Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 36: Europe Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 37: Europe Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 38: Europe Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031
Figure 39: Europe Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031
Figure 40: Europe Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031
Figure 41: Europe Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031
Figure 42: Europe Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031
Figure 43: Asia Pacific Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 44: Asia Pacific Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 45: Asia Pacific Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 46: Asia Pacific Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 47: Asia Pacific Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031
Figure 48: Asia Pacific Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031
Figure 49: Asia Pacific Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031
Figure 50: Asia Pacific Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031
Figure 51: Asia Pacific Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031
Figure 52: Latin America Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 53: Latin America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 54: Latin America Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 55: Latin America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 56: Latin America Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031
Figure 57: Latin America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031
Figure 58: Latin America Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031
Figure 59: Latin America Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031
Figure 60: Latin America Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031
Figure 61: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 62: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 63: Middle East & Africa Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 64: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 65: Middle East & Africa Cell Line Authentication and Characterization Tests Market Attractiveness Index Analysis, by Test Type, 2021–2031
Figure 66: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value Share Analysis, by Application, 2020 and 2031
Figure 67: Middle East & Africa Cell Line Authentication and Characterization Tests Market Attractiveness Analysis, by Application, 2021–2031
Figure 68: Middle East & Africa Cell Line Authentication and Characterization Tests Market Value Share Analysis, by End-user, 2020 and 2031
Figure 69: Middle East & Africa Cell Line Authentication and Characterization Tests Market attractiveness index Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cell Line Authentication and Characterization Tests Market Trends, 2021-2031
